The European Commission received green light to authorize the use of lactic acid to reduce microbial surface contamination in beef carcasses. This approval follows the positive opinion of the European Food Safety Authority (EFSA) panel earlier this year. The European Council's decision last week not to block the use of lactic acid as a decontaminant in beef slaughterhouses will improve hygiene and boost food safety for consumers, according to Purac. The European Commission will be able to approve the treatment within weeks in the absence of formal objection by the European parliament. Lactic acid is already widely used to reduce microbial surface contamination in the USA and was deemed safe by EFSA (the European Food Safety Authority) last year.


"Currently, European law permits only the use of water for beef carcass decontamination, so this is an important step for the European beef industry," said Lonneke van Dijk, category manager meat at Purac. "Lactic acid and its derivatives have been used as natural antimicrobial agents in many parts of the food industry for years, so have a long history of safe use. Treating beef with a lactic acid wash has proven effective in reducing foodborne pathogens and will be a valuable additional aspect of HACCP practices in slaughterhouses, providing the European meat industry another effective solution to fight various food-borne pathogens. Purac's lactic acid portfolio has formed part of multiple hurdle food safety programmes in the meat industry for several decades."


vertaalmachine
De Europese Commissie heeft groen licht om het gebruik van melkzuur toe te microbiële verontreiniging in runderkarkassen te verminderen. Deze goedkeuring volgt het positieve advies van de Europese Autoriteit voor voedselveiligheid (EFSA) paneel eerder dit jaar. De Europese Raad besluit van vorige week niet tot het gebruik van melkzuur te blokkeren als een ontsmettend middel in rundvlees slachthuizen zal verbeteren de hygiëne en het vergroten van de voedselveiligheid voor de consument, volgens Purac. De Europese Commissie zal in staat zijn om de behandeling binnen enkele weken goed te keuren in de afwezigheid van formeel bezwaar door het Europees Parlement. Melkzuur wordt al veel gebruikt om microbiële verontreiniging in de Verenigde Staten te verminderen en werd veilig geacht door de EFSA (de Europese Autoriteit voor voedselveiligheid) vorig jaar.


"Op dit moment, het Europese recht alleen het gebruik van water voor rundvlees karkas ontsmetting toelaat, dus dit is een belangrijke stap voor de Europese rundvlees industrie", aldus Lonneke van Dijk, category manager vlees bij Purac. "Melkzuur en zijn derivaten zijn gebruikt als natuurlijke antimicrobiële middelen in vele delen van de voedingsindustrie al jaren, dus hebben een lange geschiedenis van veilig gebruik. Behandeling van rundvlees met een melkzuur wassen is bewezen effectief in het verminderen van door voedsel overgedragen pathogenen en zal een waardevolle aanvullende aspect van HACCP in slachthuizen, het verstrekken van de Europese vleesindustrie een andere effectieve oplossing om verschillende door voedsel overgedragen pathogenen te bestrijden. melkzuur Purac portefeuille heeft deel uitgemaakt van meerdere hindernis voedselveiligheid programma's in de vleesindustrie gedurende meerdere decennia. "

Purac Biomaterials builds facility for biomedical polymers in Georgia
Time:12/10/2012 10:52:48 AMLarger Medium SmallerSource:Purac Biomaterials
The company will invest $20 million into the manufacturing operation, creating more than 30 new jobs in Georgia, USA.


Purac Biomaterials will open a new biomaterials manufacturing facility in Tucker. The company will invest $20 million into the manufacturing operation, creating more than 30 new jobs, according to the announcement by Gov. Nathan Deal.

"With Georgia's rich resources and assets within the bioscience industry, Purac Biomaterials will find a good home in our state," said Deal. "Being able to sit down with a company's leaders to ask for their business is a tremendous advantage for economic development. This commitment will further help me in making Georgia the No. 1 place in the nation to do business."

Purac Biomaterials, a part of Dutch-based Purac, develops, manufactures and markets resorbable polymers and monomers worldwide under the PURASORB brand name. The products and services support development from early stage research and development to market introduction and large scale commercial supply. Purac is a subsidiary of CSM with business in bakery supplies, food preservation solutions and bio-based chemicals. CSM already operates two facilities in Tucker.

Deal met with CSM's CEO Gerard Hoetmer and toured the company's headquarters in the Netherlands while in Europe in July, during one of his four economic development missions of the year. The mission also included visits to Vanderlande Industries, TenCate and Philips Electronics, Dutch companies that already operate facilities in the state. The Netherlands ranks fourth among European investors in Georgia.

The company will produce resorbable polymers for the medical and pharmaceutical industry in a 60,000-square foot facility in Tucker, whose acquisition was completed on Nov. 28. The facility is expected to be operational in early 2014. The Georgia Department of Economic Development led the recruitment of Purac Biomaterials with support from the DeKalb County Office of Economic Development and the Metro Atlanta Chamber of Commerce. Amanda Shailendra and Glen Whitley with the Health Sciences and Advanced Technology team at GDEcD managed the project for the state.

"Purac's selection of Metro Atlanta for its North American R&D and specialty polymer production is recognition of our region's robust growth in pharmaceutical and other health-related markets," said David Hartnett, vice president bioscience and health IT development for the Metro Atlanta Chamber. "The bioscience industry already employs more than 105,000 people in Georgia. This new facility will take advantage of our uniquely skilled labor mix in metropolitan Atlanta, and it adds to an already impressive supply chain existing here for medical devices and drug delivery products."

bron: http://us.industrysourcing.com/news/263917.aspx